Evidence map›Paper›PMID 35475640›Full record

ArticleMicrobiology spectrum2022

Cefotaxime Exposure Selects Mutations within the CA-Domain of

Eleftheria Trampari, Chuanzhen Zhang, Kathryn Gotts, George M Savva, Vassiliy N Bavro, Mark Webber

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Eleftheria TrampariQuadram Institute Bioscience, Norwich, United Kingdom.
Chuanzhen ZhangQuadram Institute Bioscience, Norwich, United Kingdom.
Kathryn GottsQuadram Institute Bioscience, Norwich, United Kingdom.
George M SavvaQuadram Institute Bioscience, Norwich, United Kingdom.
Vassiliy N BavroSchool of Biological Sciences, University of Essexgrid.8356.8, Colchester, United Kingdom.
Mark WebberQuadram Institute Bioscience, Norwich, United Kingdom.ORCID 0000-0001-9169-7592
Quadram Institute · GBSouth China Agricultural University · CNUniversity of East Anglia · GBUniversity of Essex · GB

Funding

Biotechnology and Biological Sciences Research Council BB/CCG1860/1Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10349Medical Research Council MR/L015080/1
6 · The paper itself

Abstract

Cephalosporins are important beta lactam antibiotics, but resistance can be mediated by various mechanisms including production of beta lactamase enzymes, changes in membrane permeability or active efflux. We used an evolution model to study how Salmonella adapts to subinhibitory concentrations of cefotaxime in planktonic and biofilm conditions and characterized the mechanisms underpinning this adaptation. We found that Salmonella rapidly adapts to subinhibitory concentrations of cefotaxime via selection of multiple mutations within the CA-domain region of EnvZ. We showed that changes in this domain affect the ATPase activity of the enzyme and in turn impact OmpC, OmpF porin expression and hence membrane permeability leading to increased tolerance to cefotaxime and low-level resistance to different classes of antibiotics. Adaptation to cefotaxime through EnvZ also resulted in a significant cost to biofilm formation due to downregulation of curli. We assessed the role of the mutations identified on the activity of EnvZ by genetic characterization, biochemistry and

Indexed as

Bacterial Outer Membrane ProteinsCefotaximeAnti-Bacterial AgentsBiofilmsDrug Resistance, MicrobialMutationPorinsSalmonellaAnti-Bacterial AgentsBacterial Outer Membrane ProteinsCefotaximePorinsantimicrobial resistancebiofilmsevolutiontwo component systems

Identifiers

PMID35475640
PMCPMC9241649
OpenAlexW4224981713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.